2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Clinical and Radiological Predictors of Transplant Renal Artery Stenosis (TRAS)

H. Wadei,¹ D. Hodge,² L. White,² A. Ayub,³ N. Aslam,³ T. Gonwa,¹ G. Frey,⁴ D. Sella,⁴ M. Mai.¹
Clinical and Virologic Outcomes in High-Risk Adult EBV D+/R- Organ Transplant Recipients

D. Kumar, N. Patil, S. Husain, C. Chaparro, A. Humar.
Clinical Consequences of Immune-Mediated Allograft Arteriosclerosis: A Population Based Study

A. Loupy, Vernerey, Viglietti, Aubert, Duong van Huyen, Bruneval, Empana, Suberbielle, Glotz, Jouven, Legendre, Lefaucheur.
Clinical Course of Pre-Existing Monoclonal Gammopathies Following Kidney Transplant

C. Johnson.
Clinical Impact of 18F-FDG-PET/CT in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma

S. Lee, S. Kim.
Clinical Outcome of Patients With De Novo C1q Binding Donor-Specific HLA Antibodies After Renal Transplantation

J. Bamoulid,¹ A. Roodenburg,² O. Staeck,¹ C. Schoenemann,² N. Lachmann,² K. Budde.¹
Clinical Outcomes of Kidney Transplan Recipients After Sirolimus Or Everolimus Conversion. Experience in a Single Center

L. Mesa, E. Manzi, M. Valderrama, J. Posada, J. Schweineberg, C. Duran, G. Echeverri, J. Villegas, O. Serrano, L. Caicedo.
Clinical Outcomes of Living Kidney Donors With Medullary Sponge Kidney

W. Cheungpasitporn, C. Thongprayoon, B. Brabec, W. Kittanamongkolchai, S. Erickson.
Clinical Relevance of C3d-Binding Donor-Specific Antibodies in Late Kidney Allograft Failure

J. Lan, D. Gjertson, Y. Zheng, DeKAF Investigators, E. Reed, M. Cecka.
Clinical Significance of Estimated DSA MFI Values at 1,000 C1q MFI for Differentiation Between Harmful and Harmless DSA

K. Horimi,¹ T. Akaza,² K. Kuroki,² S. Sakamoto,² Y. Matsuoka,¹ Y. Watarai,² S. Narumi,² A. Katayama,³ K. Uchida,¹ T. Kobayashi.⁴

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z